|
TTC17 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.277600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.329600E-01 |
| Normal-vs-Stage2 |
7.341600E-01 |
| Normal-vs-Stage3 |
3.583400E-01 |
| Normal-vs-Stage4 |
8.220400E-01 |
| Stage1-vs-Stage2 |
3.397600E-01 |
| Stage1-vs-Stage3 |
1.129410E-01 |
| Stage1-vs-Stage4 |
7.865200E-01 |
| Stage2-vs-Stage3 |
7.215600E-01 |
| Stage2-vs-Stage4 |
6.906200E-01 |
| Stage3-vs-Stage4 |
4.572000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.366400E-01 |
| Normal-vs-AfricanAmerican |
8.993600E-01 |
| Normal-vs-Asian |
8.913800E-01 |
| Caucasian-vs-AfricanAmerican |
9.051400E-01 |
| Caucasian-vs-Asian |
8.714200E-01 |
| AfricanAmerican-vs-Asian |
9.074400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.947200E-01 |
| Normal-vs-Female |
1.635180E-01 |
| Male-vs-Female |
2.613500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.565600E-01 |
| Normal-vs-Extreme_Weight |
2.074400E-01 |
| Normal-vs-Obese |
5.082400E-01 |
| Normal-vs-Extreme_Obese |
1.357640E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.813800E-01 |
| Normal_Weight-vs-Obese |
5.816400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.075400E-01 |
| Extreme_Weight-vs-Obese |
9.797700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.067000E-01 |
| Obese-vs-Extreme_Obese |
2.131200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.600200E-02 |
| Normal-vs-Age(41-60Yrs) |
2.769400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.699600E-02 |
| Normal-vs-Age(81-100Yrs) |
9.180000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.709600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.435900E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.220200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.417100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.084200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.699600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.352200E-01 |
| Normal-VS-Type2 PRCC |
1.161390E-01 |
| Normal-VS-KIRP CIMP |
9.544100E-02 |
| Normal-VS-Unclassified PRCC |
5.925600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.856760E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.919000E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.198800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.104200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.012040E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.002410E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.008000E-02 |
| Normal-vs-N1 |
8.835900E-02 |
| Normal-vs-N2 |
9.229400E-01 |
| N0-vs-N1 |
1.136080E-02 |
| N0-vs-N2 |
6.142800E-01 |
| N1-vs-N2 |
4.260200E-01 |
|
|
